Patent Term Extension Application for LYNKUET (elinzanetant). Patent No. 10,195,205 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1011

Patent Term Extension Application for LYNKUET (elinzanetant). Patent No. 10,195,205

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Patent Term Extension Application

LYNKUET (elinzanetant)

Morrison & Foerster LLP

KaNDY Therapeutics Limited

Patent No. 10,195,205

OPEN